tradingkey.logo

Vivos Therapeutics Inc

VVOS
View Detailed Chart
1.550USD
+0.050+3.33%
Close 02/06, 16:00ETQuotes delayed by 15 min
12.81MMarket Cap
LossP/E TTM

Vivos Therapeutics Inc

1.550
+0.050+3.33%
Intraday
1m
30m
1h
D
W
M
D

Today

+3.33%

5 Days

-4.32%

1 Month

-34.87%

6 Months

-66.52%

Year to Date

-23.65%

1 Year

-61.73%

View Detailed Chart

Key Insights

Vivos Therapeutics Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 104 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 5.00.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Vivos Therapeutics Inc's Score

Industry at a Glance

Industry Ranking
104 / 205
Overall Ranking
281 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Vivos Therapeutics Inc Highlights

StrengthsRisks
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Growing
The company is in a growing phase, with the latest annual income totaling USD 15.03M.
Fairly Valued
The company’s latest PE is -0.87, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 1.30M shares, increasing 27.84% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 304.16K shares of this stock.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
5.000
Target Price
+233.33%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Vivos Therapeutics Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Vivos Therapeutics Inc Info

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Ticker SymbolVVOS
CompanyVivos Therapeutics Inc
CEOHuntsman (R. Kirk)
Websitehttps://vivos.com/
KeyAI